NCT06008197View on ClinicalTrials.gov

A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients

PHASE3RecruitingINTERVENTIONAL
Enrollment

5,200

Participants

Timeline

Start Date

January 17, 2024

Primary Completion Date

April 30, 2026

Study Completion Date

April 30, 2026

Conditions
Heart FailureAcute Heart Failure
Interventions
DRUG

Finerenone

Oral finerenone

DRUG

Placebo

Matching oral placebo

Trial Locations (4)

33434

RECRUITING

Boca Raton, FL Investigative Site, Boca Raton

64111

RECRUITING

Kansas City, MO Investigative Site, Kansas City

80045

NOT_YET_RECRUITING

Aurora, CO Investigative Site, Aurora

80204

NOT_YET_RECRUITING

Denver, CO Investigative Site, Denver

Sponsors

Collaborators (1)

Bayer
All Listed Sponsors
collaborator

St. Luke's Hospital, Kansas City, Missouri

OTHER

collaborator

Bayer

INDUSTRY

lead

Colorado Prevention Center

OTHER